Cargando…

Reprogrammed Functional Brown Adipocytes Ameliorate Insulin Resistance and Dyslipidemia in Diet-Induced Obesity and Type 2 Diabetes

Brown adipocytes (BAs) play important roles in body temperature regulation, energy balance, and carbohydrate and lipid metabolism. Activities of BAs are remarkably diminished in obese and diabetic patients, providing possibilities of transplanting functional BAs resulting in therapeutic benefit. Her...

Descripción completa

Detalles Bibliográficos
Autores principales: Kishida, Tsunao, Ejima, Akika, Yamamoto, Kenta, Tanaka, Seiji, Yamamoto, Toshiro, Mazda, Osam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4624936/
https://www.ncbi.nlm.nih.gov/pubmed/26365511
http://dx.doi.org/10.1016/j.stemcr.2015.08.007
_version_ 1782397894531219456
author Kishida, Tsunao
Ejima, Akika
Yamamoto, Kenta
Tanaka, Seiji
Yamamoto, Toshiro
Mazda, Osam
author_facet Kishida, Tsunao
Ejima, Akika
Yamamoto, Kenta
Tanaka, Seiji
Yamamoto, Toshiro
Mazda, Osam
author_sort Kishida, Tsunao
collection PubMed
description Brown adipocytes (BAs) play important roles in body temperature regulation, energy balance, and carbohydrate and lipid metabolism. Activities of BAs are remarkably diminished in obese and diabetic patients, providing possibilities of transplanting functional BAs resulting in therapeutic benefit. Here, we show generation of functional BAs by cellular reprogramming procedures. Transduction of the PRDM16 gene into iPSC-derived embryoid bodies induced BA phenotypes (iBAs). Moreover, normal human fibroblasts were directly converted into BAs (dBAs) by C/EBP-β and C-MYC gene transduction. Approximately 90% of the fibroblasts were successfully converted within 12 days. The dBAs were highly active in mitochondrial biogenesis and oxidative metabolism. Mouse dBAs were induced by Prdm16, C/ebp-β, and L-myc genes, and after transplantation, they significantly reduced diet-induced obesity and insulin resistance in an UCP1-dependent manner. Thus, highly functional BAs can be generated by cellular reprogramming, suggesting a promising tailor-made cell therapy against metabolic disorders including type 2 diabetes mellitus.
format Online
Article
Text
id pubmed-4624936
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-46249362015-11-19 Reprogrammed Functional Brown Adipocytes Ameliorate Insulin Resistance and Dyslipidemia in Diet-Induced Obesity and Type 2 Diabetes Kishida, Tsunao Ejima, Akika Yamamoto, Kenta Tanaka, Seiji Yamamoto, Toshiro Mazda, Osam Stem Cell Reports Article Brown adipocytes (BAs) play important roles in body temperature regulation, energy balance, and carbohydrate and lipid metabolism. Activities of BAs are remarkably diminished in obese and diabetic patients, providing possibilities of transplanting functional BAs resulting in therapeutic benefit. Here, we show generation of functional BAs by cellular reprogramming procedures. Transduction of the PRDM16 gene into iPSC-derived embryoid bodies induced BA phenotypes (iBAs). Moreover, normal human fibroblasts were directly converted into BAs (dBAs) by C/EBP-β and C-MYC gene transduction. Approximately 90% of the fibroblasts were successfully converted within 12 days. The dBAs were highly active in mitochondrial biogenesis and oxidative metabolism. Mouse dBAs were induced by Prdm16, C/ebp-β, and L-myc genes, and after transplantation, they significantly reduced diet-induced obesity and insulin resistance in an UCP1-dependent manner. Thus, highly functional BAs can be generated by cellular reprogramming, suggesting a promising tailor-made cell therapy against metabolic disorders including type 2 diabetes mellitus. Elsevier 2015-09-10 /pmc/articles/PMC4624936/ /pubmed/26365511 http://dx.doi.org/10.1016/j.stemcr.2015.08.007 Text en © 2015 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Kishida, Tsunao
Ejima, Akika
Yamamoto, Kenta
Tanaka, Seiji
Yamamoto, Toshiro
Mazda, Osam
Reprogrammed Functional Brown Adipocytes Ameliorate Insulin Resistance and Dyslipidemia in Diet-Induced Obesity and Type 2 Diabetes
title Reprogrammed Functional Brown Adipocytes Ameliorate Insulin Resistance and Dyslipidemia in Diet-Induced Obesity and Type 2 Diabetes
title_full Reprogrammed Functional Brown Adipocytes Ameliorate Insulin Resistance and Dyslipidemia in Diet-Induced Obesity and Type 2 Diabetes
title_fullStr Reprogrammed Functional Brown Adipocytes Ameliorate Insulin Resistance and Dyslipidemia in Diet-Induced Obesity and Type 2 Diabetes
title_full_unstemmed Reprogrammed Functional Brown Adipocytes Ameliorate Insulin Resistance and Dyslipidemia in Diet-Induced Obesity and Type 2 Diabetes
title_short Reprogrammed Functional Brown Adipocytes Ameliorate Insulin Resistance and Dyslipidemia in Diet-Induced Obesity and Type 2 Diabetes
title_sort reprogrammed functional brown adipocytes ameliorate insulin resistance and dyslipidemia in diet-induced obesity and type 2 diabetes
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4624936/
https://www.ncbi.nlm.nih.gov/pubmed/26365511
http://dx.doi.org/10.1016/j.stemcr.2015.08.007
work_keys_str_mv AT kishidatsunao reprogrammedfunctionalbrownadipocytesameliorateinsulinresistanceanddyslipidemiaindietinducedobesityandtype2diabetes
AT ejimaakika reprogrammedfunctionalbrownadipocytesameliorateinsulinresistanceanddyslipidemiaindietinducedobesityandtype2diabetes
AT yamamotokenta reprogrammedfunctionalbrownadipocytesameliorateinsulinresistanceanddyslipidemiaindietinducedobesityandtype2diabetes
AT tanakaseiji reprogrammedfunctionalbrownadipocytesameliorateinsulinresistanceanddyslipidemiaindietinducedobesityandtype2diabetes
AT yamamototoshiro reprogrammedfunctionalbrownadipocytesameliorateinsulinresistanceanddyslipidemiaindietinducedobesityandtype2diabetes
AT mazdaosam reprogrammedfunctionalbrownadipocytesameliorateinsulinresistanceanddyslipidemiaindietinducedobesityandtype2diabetes